Skip to main content
Browse Subject Areas

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

  • Loading metrics

Stigma in coronavirus disease-19 survivors in Kashmir, India: A cross-sectional exploratory study

  • Shabir Ahmad Dar ,

    Roles Conceptualization, Methodology, Writing – original draft, Writing – review & editing

    Affiliation Department of Psychiatry, Government Medical College, Srinagar, India

  • Syed Quibtiya Khurshid,

    Roles Conceptualization, Supervision, Writing – review & editing

    Affiliation Department of Surgery, SKIMS Medical College, Srinagar, India

  • Zaid Ahmad Wani,

    Roles Conceptualization, Writing – review & editing

    Affiliation Department of Psychiatry, Government Medical College, Srinagar, India

  • Aaliya Khanam,

    Roles Conceptualization, Writing – review & editing

    Affiliation Department of Psychiatry, Government Medical College, Srinagar, India

  • Inaamul Haq,

    Roles Formal analysis, Supervision, Writing – review & editing

    Affiliation Department of Social and Preventive Medicine, Government Medical College, Srinagar, India

  • Naveed Nazir Shah,

    Roles Conceptualization, Data curation, Writing – review & editing

    Affiliation Department of Chest Medicine, Government Medical College, Srinagar, India

  • Mir Shahnawaz,

    Roles Conceptualization, Data curation, Writing – review & editing

    Affiliation Department of Chest Medicine, Government Medical College, Srinagar, India

  • Hena Mustafa

    Roles Conceptualization, Data curation, Writing – review & editing

    Affiliation Department of Chest Medicine, Government Medical College, Srinagar, India


23 Dec 2020: Dar SA, Khurshid SQ, Wani ZA, Khanam A, Haq I, et al. (2020) Correction: Stigma in coronavirus disease-19 survivors in Kashmir, India: A cross-sectional exploratory study. PLOS ONE 15(12): e0244715. View correction



Coronavirus disease-19 (COVID-19) has not only spawned a lot of stigma and discrimination towards its survivors but also to their corpses. We aimed to assess the magnitude and correlates of stigma in these survivors, on return to their communities.


This was a cross-sectional, hospital-based, exploratory study conducted by the postgraduate department of psychiatry, in collaboration with the postgraduate department of chest medicine, Govt. medical college, Srinagar. The study was performed among COVID-19 survivors, who attended the outpatient department after their discharge from the hospital. Socio-demographic characteristics were recorded through semi-structured proforma. Stigma was measured by the stigma questionnaire. Data was analyzed using descriptive statistics and regression analysis.


A total of 91 survivors consented to participate in the study. Almost half (46.2%) of them were in the age group of 30–49 years and close to two-thirds (68.1%) were males. About three–fourths (74.7%) were from the urban background. The mean time from hospital discharge to study entry was 11.7±5.1 [Range(R) = 7–21] days. 98% of survivors provided at least one stigma endorsing response and the total mean stigma score was 28.5±7.1[R = 6–39]. The mean stigma sub-scores were highest for enacted stigma (7.6±1.8) [R = 2–9] and externalized stigma (15.0±4.1) [R = 1–20]. Enacted stigma was significantly high in males as compared to females. Enacted stigma and internalized stigma were both associated with education. Enacted stigma, externalized stigma, disclosure concerns, and total stigma was significantly associated with the occupation. Being unemployed and time since discharge were identified as independent predictors of total stigma.


Our study results showed high levels of enacted and externalized stigma among COVID-19 survivors. Enacted stigma was more among males and in those who were highly educated. Survivor centered and community-driven anti-stigma programs are the need of the hour to promote the recovery and community re-integration of these survivors.


The unprecedented outbreak of the COVID-19 in early December 2019 from a wet market in Wuhan aroused enormous attention globally [1]. As of August 21, 2020, the total number of COVID-19 cases in India are 2,975,701 with 697,330 active cases, and 2,222,577 cured/discharged patients after its first case in the country on January 30, 2020. As many as 55,794 people have died and the recovery rate in the country stands at 74.69 percent [2].

Since the contagion gets rapidly transmitted among the persons in close contact, a wide fragment of the world's population is currently restricted to their homes, owing to nationwide lockdowns and home-confinement strategies [3]. Infected patients may develop severe and even fatal acute respiratory distress syndrome or acute respiratory failure landing up in intensive care [3, 4]. Apart from causing anxiety, depression, posttraumatic symptoms, and grief in the families due to the horrific death of COVID-19 patients, this rapidly spreading and the unpredictable pandemic has lead to discrimination and stigmatization of its survivors [5]. Upon their reintegration in society, the survivors are greeted with hostile stares even from their family members and neighbors [6].

Stigma constitutes negative attitudes and beliefs that discredit an individual or group of individuals leading to prejudice, societal exclusion, discrimination, marginalization, and racism [7]. Thus stigma can lead to experiences and feelings of blame, shame, worthlessness, isolation, social exclusion, and discrimination in accessing social amenities and healthcare services [8, 9]. Socially undesirable manifestations like prejudice and discrimination expressed against those with the stigmatizing attributes are known as enacted stigma whereas the feeling of shame, guilt, or worthlessness experienced as a result of having the stigmatizing attribute is referred to as internalized stigma [10].

COVID-19 stigma is largely based on community fear that its survivors are still contagious, therefore the present study was taken to quantify stigma attached to its survivors, and to categorize the type of stigma faced, in the light of COVID-19 pandemic.


Study design, setting, and participants

This was a cross-sectional, hospital-based, exploratory study conducted by the postgraduate department of psychiatry, in collaboration with the postgraduate department of chest medicine of Govt. Medical College, Srinagar. The study was conducted over one and a half months from April 15 to June 1, 2020. The survivors enrolled in our study were greater than 18 years of age and were of either gender. The study sample consisted of survivors who followed up after discharge in the outdoor patient department. The sample was selected by systematic random sampling, in which every third survivor was taken.

Survivors with a prior history of any psychiatric illnesses or chronic medical conditions like tuberculosis and human immunodeficiency virus (HIV) syndrome were excluded from the study. The participant information sheet, explaining the purpose and scope of the study was given (or read in case of illiterate) to survivors before seeking their consent to participate. They were also given an option to opt-out of the study at any point in time. The highest level of confidentiality and anonymity was maintained.


Demographics such as age, gender, marital status, educational level, employment status, and place of residence (urban/rural), were recorded.

Stigma in this study was measured by the stigma questionnaire. The stigma questionnaire was adapted from the Ebola-related stigma questionnaire, which itself was derived from Berger’s HIV stigma scale, a validated measure of self-reported stigma in individuals infected with HIV in many cultural settings [11, 12].

The stigma questionnaire used, comprised of 15 items which measured the total stigma as enacted stigma, internalized stigma, perceived external stigma, and disclosure fears. Each item was rated on a 4-point Likert scale (0: strongly disagree, 1: disagree, 2: agree, 3: strongly agree) to describe how often the COVID-19 survivors experienced the 15 items of stigma after their discharge from the hospital. Scores were summed, with higher scores indicating greater experiences of stigma. 14 items used in our study were based on the stigma-related questionnaire used in a study done on stigma in Ebola virus disease (2014) [13]. To adapt to this disease and our setting, the Ebola-related stigma questionnaire was evaluated by an expert panel comprising of, a psychiatrist, an epidemiologist, an infectious disease specialist, and a sociologist, and was piloted in 15 COVID-19 survivors. Based on their feedback, two items from the original Ebola-related stigma questionnaire were removed; however, one new question was added [14]. The final adapted stigma questionnaire used in our study is as shown in Table 1. The reliability of the adapted stigma questionnaire was ascertained in the Kashmiri population and the Cronbach 'α' was found to be 0.92 (meaning an excellent consistency).

Data collection and ethical consideration

Responses from COVID-19 survivors were obtained by trained data collectors using self-administered or interviewer-administered (for illiterate participants) formats. All participants provided written informed consent. The consent document and the research Protocols were approved by the institutional ethics committee of Govt. Medical College, Srinagar.

Statistical analysis

Microsoft Excel was used for data entry. Categorical variables were summarized as frequency and percentage. Days since discharge, domain scores, and total scores were summarized as mean, standard deviation, and range. For univariable analysis with domain scores and total score as the dependent variable, the correlation coefficient was used for days since discharge, independent-samples t-test was used for dichotomous variables, and one-way analysis of variance (ANOVA) was used for categorical variables with >2 categories. For one-way ANOVA, when homogeneity of variances assumption was violated, Brown-Forsythe F was used to report the p-value. Variables found associated with the total score at p < 0.20 in the univariable analysis were used to build a multivariable linear regression model with the total score as the dependent variable; besides, the total score was also adjusted for age and gender. Two-sided p-values were reported and p < 0.05 was considered to be statistically significant. Data analysis was done using SPSS version 23 (IBM Corp. Released 2015. IBM SPSS Statistics for Windows, Version 23.0. Armonk, NY: IBM Corp.) except for Fig 1 which was made using Stata (StataCorp LLC. Stata/IC 15.1 for Windows, Revision 03 Feb 2020. College Station, TX: USA).

Fig 1. It represents the scatter plots of changes in total stigma and sub stigma scores with time since discharge.


Out of the 95 survivors who were asked to participate in the study, four refused to consent citing health issues, as a result of which 91 survivors were taken for the final analysis. Table 2 gives a summary of the survivor’s socio-demographic characteristics. Almost half (n = 42, 46.2%) of survivors were in the age group of 30–49 years, and close to two-thirds (n = 62, 68.1%) were males, Almost three–fourths (n = 68, 74.7%) of survivors were from the urban background. The mean time from hospital discharge to study entry was 11.7±5.1 [Range(R) = 7–21] days.

98% of survivors provided at least one stigma endorsing response and the total mean stigma score was 28.5±7.1 (R = 6–39). The mean stigma sub-scores were 7.6±1.8 (R = 2–9) for enacted stigma, 15.0±4.1 (R = 1–20) for externalized stigma and 3.2± 2.1(R = 0–7) for internalized stigma. The mean disclosure concern subscale score was 2.7±1.4 (R = 0–5) as shown in Table 3.

Survivors experienced the highest score in all the three questions of enacted stigma subscale (‘people minimized socializing’, ‘lost friends’, and ‘being hurt by how people reacted’). In the externalized stigma subscale survivors experienced the highest score in ‘people would not want someone who has had COVID-19 around their children’, ‘people would be uncomfortable around someone who has had COVID-19’ and ‘people who have had COVID-19 are rejected’ as can be seen in Fig 2.

Fig 2. It is showing individual responses to stigma questionnaire by the study participants.

Table 4 summarizes the comparison of externalized stigma, internalized stigma, enacted stigma, disclosure concerns, and total stigma, with socio-demographic variables among COVID-19 survivors. Enacted stigma was more among males as compared to females and was statistically significant (p = 0.029).

Enacted stigma and internalized stigma were both associated with education. Enacted stigma was more in highly educated in comparison to the internalized stigma which was more in less educated survivors. However, education was not significantly associated with the total stigma score (p = 0.569).Enacted stigma (p‹0.001), externalized stigma (p = 0.005), disclosure concerns (p = 0.001) and total stigma (p = 0.006) was significantly associated with occupation of the survivors. After adjusting for age, gender, marital status, and time since discharge, COVID-19 survivors who were farmers [β = -7.61, 95% CI: -12.81 to -2.42-, p = 0.005], were less likely to experience stigma as compared to unemployed. Stigma significantly decreased with increasing time since discharge after adjusting for age, gender, marital status, and occupation. [β = -0.66, 95% CI: -0.93 to -0.39, p‹0.001](See Table 5).

Table 5. Multivariable linear regression analysis results for total score.


The survival of human civilization is being challenged by the emergence of COVID-19 infection, which is quickly intruding newer territories all over the globe [15]. In pandemics, there is a general increase in the stigmatization as has been seen in severe acute respiratory syndrome (SARS) epidemic or the bubonic plague [1618]. The level of disgrace and shame linked with an infectious disease is solely based on the knowledge about the disease and the available treatment options [19]. Mass fear of COVID-19 is likely due to the uncertain character and unpredictable course of the disease, perceived risk of acquiring the infection and non- availability of FDA approved treatment, unpredictable outcome, high fatality, and novelty of the infection which can generate negative psychological responses including maladaptive behavior, and avoidance reaction among people. Thus people are likely to be labeled, stereotyped, and discriminated against, treated differently, because of real or perceived links with the disease; therefore, the first quantitative assessment study was taken to determine the prevalence of stigma, its socio-demographic correlates, and association with time since discharge among COVID-19 survivors in a developing country.

The key finding in our study is high levels of enacted and perceived externalized stigma reported by survivors. Our findings corroborate with many reports of discrimination, prejudice, and social isolation that arose during other infective pandemics [20, 21]. Our findings are in line with the findings from a comparative study in Hong Kong that reported high levels of externalized stigma in SARS survivors in comparison to HIV/AIDS, and tuberculosis [22].

Firstly stigma brings disgraces that set a person apart from others [23] and markedly increases the suffering of people with the disease. Secondly, people with the disease may hide symptoms to avoid discrimination and even conceal important travel history or those at risk of catching it may avoid seeking health care till late-thus making it easier for community transmission and harder for public health authorities to control the pandemic. Thus, such an environment can fuel harmful stereotypes and undermine social cohesion. Thirdly, Stigma can lead people to physical violence and hate crimes [24, 25]. Stigma can even make families of frontline healthcare workers pressurize them to quit jobs and de-motivate them in carrying their routine duties.

We observed relatively little internalized stigma, suggesting survivor self-worth and confidence. Our results contradict with the findings of the study on HIV/AIDS patients in Hong Kong [26] and Uganda [27], where such patients reported worthlessness, guilt, shame, and self-blame.

Our findings also partly contradict with the short term and smaller sample cross-sectional studies in Sierra Leone [28, 29], Liberia [30], Guinea [31], and DR Congo [32], which reported that EVD survivors experience several forms of internalized and enacted stigma. In contrast to our study, a high level of internalized stigma was reported in EVD survivors in Sierra Leone following their return to communities. In contradiction to our study results, A.F.Almutairi et. al found internalized stigma to be common in frontline health care workers in Middle East Respiratory Syndrome (MERS) [33].

Minimization of social communications, losing friends, being unfriended on various social media platforms, being verbally abused, being called by names, and being critically commented were reported by the COVID-19 survivors. These reports are congruent with the common forms of stigma reported by other infectious disease survivors in the literature worldwide [34]. Our findings also resonate with the previous reports of stigma in SARS victims in Hong Kong [7]. Stigma with SARS victims has been seen in many domains of everyday life, like the workplace, schools, health services, restaurants, and shopping malls. The perceived linkage between SARS and ethnicity led to the irrational avoidance of Asians (especially Chinese) in many parts of the world [35]. The stigma with SARS victims has been of such an extent that stringent restrictions were imposed on travelers from Asia [36, 37]. Many literary and media reports revealed multiple instances of survivors experiencing enacted stigma during the ongoing COVID-19 pandemic. One such report is an incident wherein a COVID-19 positive pregnant woman was abandoned, by her family after her delivery, in India [38].

COVID-19 survivors also reported that they were mocked by their communities, asked to vacate the houses by their landlords, abandoned, denied access to private transport, socially boycotted, and fired from their former private jobs [38].

COVID-19 survivors are ostracized, which prevents their social reintegration. Social isolation and losing friends can lead to increased levels of psychological distress. Disclosure concerns can lead to delayed access to medical care, low adherence to medical therapy, and reduced quality of life. Similar concerns have been reported during other infectious pandemics, as well [39, 40].

Similar results have also been reported by other qualitative studies on COVID-19, which revealed that people experienced discrimination, suspicion, and avoidance by neighborhood, insecurity regarding properties, workplace prejudice, and withdrawal from social events, even after containment of epidemics [41].

Losing jobs leaves the individuals unable to make both ends meet and this sudden misfortune adds to their guilt, frustration, depression, and mental anguish-ultimately leading to functional impairment and increased rates of suicide [42].

The common types of externalized stigma faced by COVID-19 survivors were that people would not want them around their children and people would be uncomfortable around them. This could be explained by the irrational fears of contagiousness among people about COVID-19 survivors, even after their recovery. Concordant to these findings of our study, similar concerns were reported during other infectious pandemics [13].

Our study findings reveal that enacted stigma and internalized stigma were both associated with education. Enacted stigma was more in those who were highly educated. The possible reasons for higher enacted stigma in highly educated could be that higher education is associated with better job prospects, a high chance of being employed, and more public interaction thereby more chances of encountering enacted stigma.

In our study stigma significantly decreased with increasing time since discharge. Similar results were also reported by Overholt et al who found that the levels of stigma at follow-up visits were far less than the stigma at baseline visits [13]. Thus it can be concluded that the period immediately after community re-entry is when stigmatization is at greatest. Similar results were also reported in SARS where stigma decreased, but never completely disappeared, after the outbreak [35].

The mental health impact of surviving COVID-19 is enormous, and previous studies have reported that psychological distress, anxiety, and depression are widespread among COVID-19 survivors [43, 44].

Although the impact of COVID 19 stigma on mental health of survivors is not well understood, stigma induced psychological distress and anxiety have been found to be associated with adverse mental health outcome among HIV/AIDS patients [45].

Since infectious virus diseases share similar stigmatizing attributes, it is possible that COVID-19 stigma may be contributing to the mental health complications among its survivors [46]. Thus, it is likely that stigma reduction strategies will help reduce the mental health burden among COVID-19 survivors.


The high prevalence of enacted and externalized stigma highlights the need for consultation-liaison services to work in proximity to medical services. Apart from working in proximity to the hospital, Consultation-liaison services need to have a community-based approach as well, to ensure effective follow-up for survivors after their discharge. We hope that our study will assist and aid in planning consultation-liaison services and increase understanding of stigma associated with COVID-19 infection.

Drawing lessons from HIV/AIDS and Ebola-related stigma, several COVID-19 centered and community-driven strategies need to be framed, that could contribute to recovery and community reintegration of survivors. Long-term psychosocial community-counseling, psychoeducation, and enhancement of the coping skills of survivors should be focused upon.

Recruitment and training of trusted opinion leaders that can spread accurate de-stigmatizing messages within communities, minimizing social isolation and promoting the economic empowerment of survivors, and affected communities should be focused upon.


First, our study employed a cross-sectional design and, therefore we cannot infer causality between independent and outcome variables. Second, our findings are only applicable to COVID-19 survivors in Kashmir and can’t be generalized to the whole of India. Third, the majority of study participants were residents of urban environ, so survivors living in remote rural areas may have a different experience. Fourth, the period immediately after community re-entry maybe when stigmatization was greatest and maybe the over-representation of stigma. Fifth, as there is no validated measure of COVID-19 stigma, we adapted the Ebola- related stigma questionnaire, which has been validated for use in persons with Ebola virus disease.

Future directions

1. Going forward, well-designed large scale prospective research is required to have a deeper understanding of how stigma changes over time.

2. Further research on the community reintegration experience of COVID-19 survivors is warranted.


Our study results showed high levels of enacted and externalized stigma among COVID-19 survivors. Enacted stigma was more among males and in those who were highly educated. Hence there is a need to develop approaches to prevent and minimize such stigma during the ongoing outbreak and also in its immediate aftermath.


The authors are also grateful to COVID-19 survivors who generously participated in this study.


  1. 1. Lu H, Stratton CW, Tang YW. Outbreak of pneumonia of unknown etiology in Wuhan, China: The mystery and the miracle. Journal of medical virology. 2020 Apr; 92(4):401–2. pmid:31950516
  2. 2. (last accessed on 22nd August 2020).
  3. 3. Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. The lancet. 2020 Feb 15; 395(10223):497–506.
  4. 4. Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus–infected pneumonia in Wuhan, China. Jama. 2020 Mar 17; 323(11):1061–9. pmid:32031570
  5. 5. (last accessed on 21.8.2020)
  6. 6. (last accessed on 21.8.20]
  7. 7. Siu JY. The SARS-associated stigma of SARS victims in the post-SARS era of Hong Kong. Qualitative health research. 2008 Jun; 18(6):729–38. pmid:18503014
  8. 8. Frost DM. Social stigma and its consequences for the socially stigmatized. Social and Personality Psychology Compass. 2011 Nov; 5(11):824–39.
  9. 9. Earnshaw VA, Quinn DM. The impact of stigma in healthcare on people living with chronic illnesses. Journal of health psychology. 2012 Mar; 17(2):157–68. pmid:21799078
  10. 10. Scambler G. Re-framing stigma: felt and enacted stigma and challenges to the sociology of chronic and disabling conditions. Social Theory & Health. 2004 Feb 1; 2(1):29–46.
  11. 11. Wright K, Naar-King S, Lam P, Templin T, Frey M. Stigma scale revised: reliability and validity of a brief measure of stigma for HIV+ youth. Journal of adolescent health. 2007 Jan 1; 40(1):96–8. pmid:17185215
  12. 12. Jeyaseelan L, Kumar S, Mohanraj R, Rebekah G, Rao D, Manhart LE. Assessing HIV/AIDS stigma in South India: validation and abridgement of the Berger HIV stigma scale. AIDS and Behavior. 2013 Jan 1; 17(1):434–43. pmid:22246514
  13. 13. Overholt L, Wohl DA, Fischer WA, Westreich D, Tozay S, Reeves E, et al. Stigma and Ebola survivorship in Liberia: results from a longitudinal cohort study. PLoS One. 2018 Nov 28; 13(11):e0206595. pmid:30485311
  14. 14. Reinius M, Wettergren L, Wiklander M, Svedhem V, Ekström AM, Eriksson LE. Development of a 12-item short version of the HIV stigma scale. Health and Quality of Life Outcomes. 2017 Dec 1; 15(1):115. pmid:28558805
  15. 15. Jones DS. History in a crisis—lessons for Covid-19. New England Journal of Medicine. 2020 Apr 30; 382(18):1681–3. pmid:32163699
  16. 16. Washer P. Representations of SARS in the British newspapers. Social science & medicine. 2004 Dec 1; 59(12):2561–71. pmid:15474209
  17. 17. Cohn SK. Cultures of plague: medical thinking at the end of the Renaissance. Oxford University Press; 2010.
  18. 18. Murray DR, Schaller M. Threat (s) and conformity deconstructed: Perceived threat of infectious disease and its implications for conformist attitudes and behavior. European Journal of Social Psychology. 2012 Mar; 42(2):180–8.
  19. 19. Crandall CS. Multiple stigma and AIDS: Illness stigma and attitudes toward homosexuals and IV drug users in AIDS‐related stigmatization. Journal of Community & Applied Social Psychology. 1991 Jun; 1(2):165–72.
  20. 20. Denis-Ramirez E, Sørensen KH, Skovdal M. In the midst of a ‘perfect storm’: Unpacking the causes and consequences of Ebola-related stigma for children orphaned by Ebola in Sierra Leone. Children and Youth Services Review. 2017 Feb 1; 73:445–53.
  21. 21. Rabelo I, Lee V, Fallah MP, Massaquoi M, Evlampidou I, Crestani R, et al. Psychological Distress among ebola survivors Discharged from an ebola Treatment Unit in Monrovia, liberia–a Qualitative study. Frontiers in Public Health. 2016 Jul 4; 4:142. pmid:27458576
  22. 22. Mak WW, Mo PK, Cheung RY, Woo J, Cheung FM, Lee D. Comparative stigma of HIV/AIDS, SARS, and tuberculosis in Hong Kong. Social science & medicine. 2006 Oct 1; 63(7):1912–22.
  23. 23. Pescosolido BA. The public stigma of mental illness: What do we think; what do we know; what can we prove? Journal of Health and Social behavior. 2013 Mar; 54(1):1–21. pmid:23325423
  24. 24.—19-medical-help-center-about-arrival-of-two-people-fr-2123828.html (last accessed on 21.8.20)
  25. 25. (last accessed on 21.8.20)
  26. 26. Mo PK, Ng CT. Stigmatization among people living with HIV in Hong Kong: a qualitative study. Health Expectations. 2017 Oct; 20(5):943–51. pmid:28195685
  27. 27. Nattabi B, Li J, Thompson SC, Orach CG, Earnest J. Factors associated with perceived stigma among people living with HIV/AIDS in post-conflict northern Uganda. AIDS Education and Prevention. 2011 Jun; 23(3):193–205. pmid:21696239
  28. 28. Wadoum RG, Samin A, Mafopa NG, Giovanetti M, Russo G, Turay P, et al. Mobile health clinic for the medical management of clinical sequelae experienced by survivors of the 2013–2016 Ebola virus disease outbreak in Sierra Leone, West Africa. European Journal of Clinical Microbiology & Infectious Diseases. 2017 Nov 1; 36(11):2193–200.
  29. 29. Hugo M, Declerck H, Fitzpatrick G, Severy N, Gbabai OB, Decroo T. Post-traumatic stress reactions in Ebola virus disease survivors in Sierra Leone. Emerg Med (Los Angel). 2015; 5(6):1–4.
  30. 30. de St. Maurice A, Ervin E, Orone R, Choi M, Dokubo EK, Rollin PE, et al. Care of Ebola survivors and factors associated with clinical sequelae—Monrovia, Liberia. InOpen forum infectious diseases 2018 Oct (Vol. 5, No. 10, p. ofy239). US: Oxford University Press. pmid:30386807
  31. 31. Qureshi AI, Chughtai M, Loua TO, Pe Kolie J, Camara HF, Ishfaq MF, et al. Study of Ebola virus disease survivors in Guinea. Clinical Infectious Diseases. 2015 Oct 1; 61(7):1035–42. pmid:26060289
  32. 32. Kelly JD, Hoff NA, Spencer DA, Musene K, Bramble MS, McIlwain D, et al. Neurological, cognitive, and psychological findings among survivors of Ebola virus disease from the 1995 Ebola outbreak in Kikwit, Democratic Republic of Congo: a cross-sectional study. Clinical Infectious Diseases. 2019 Apr 8; 68(8):1388–93. pmid:30107392
  33. 33. Almutairi AF, Adlan AA, Balkhy HH, Abbas OA, Clark AM. “It feels like I’m the dirtiest person in the world.” Exploring the experiences of healthcare providers who survived MERS-CoV in Saudi Arabia. Journal of infection and public health. 2018 Mar 1; 11(2):187–91 pmid:28676285
  34. 34. James PB, Wardle J, Steel A, Adams J. Post‐Ebola psychosocial experiences and coping mechanisms among Ebola survivors: a systematic review. Tropical Medicine & International Health. 2019 Jun; 24(6):671–91. pmid:30843627
  35. 35. Lee S, Chan LY, Chau AM, Kwok KP, Kleinman A. The experience of SARS-related stigma at Amoy Gardens. Social science & medicine. 2005 Nov 1; 61(9):2038–46. pmid:15913861
  36. 36. Singer PA, Benatar SR, Bernstein M, Daar AS, Dickens BM, MacRae SK, et al. Ethics and SARS: lessons from Toronto. Bmj. 2003 Dec 4; 327(7427):1342–4. pmid:14656848
  37. 37. Le Dang Ha SA, Hien NQ, Maloney SA, Le Quynh Mai KC, Anh BH, Reynolds MG, Montgomery JM, Comer JA, Horby P, Plant AJ. Lack of SARS transmission among public hospital workers, Vietnam. Emerging infectious diseases. 2004 Feb; 10(2):265. pmid:15030695
  38. 38. Bagcchi S. Stigma during the COVID-19 pandemic. The Lancet. Infectious Diseases. 2020 Jul; 20(7):782 pmid:32592670
  39. 39. Livingston JD, Boyd JE. Correlates and consequences of internalized stigma for people living with mental illness: A systematic review and meta-analysis. Social science & medicine. 2010 Dec 1; 71(12):2150–61. pmid:21051128
  40. 40. Turan B, Budhwani H, Fazeli PL, Browning WR, Raper JL, Mugavero MJ, et al. How does stigma affect people living with HIV? The mediating roles of internalized and anticipated HIV stigma in the effects of perceived community stigma on health and psychosocial outcomes. AIDS and Behavior. 2017 Jan 1; 21(1):283–91. pmid:27272742
  41. 41. Brooks SK, Webster RK, Smith LE, Woodland L, Wessely S, Greenberg N, et al. The psychological impact of quarantine and how to reduce it: rapid review of the evidence. The Lancet. 2020 Feb 26.
  42. 42. Subbaraman R, Nolan L, Shitole T, Sawant K, Shitole S, Sood K, et al. The psychological toll of slum living in Mumbai, India: a mixed methods study. Social Science & Medicine. 2014 Oct 1; 119:155–69. pmid:25189736
  43. 43. Wu C, Hu X, Song J, Yang D, Xu J, Cheng K, et al. Mental health status and related influencing factors of COVID‐19 survivors in Wuhan, China. Clinical and Translational Medicine. 2020 Jun 5. pmid:32508037
  44. 44. Mazza MG, De Lorenzo R, Conte C, Poletti S, Vai B, Bollettini I, et al. Anxiety and depression in COVID-19 survivors: role of inflammatory and clinical predictors. Brain, Behavior, and Immunity. 2020 Jul 30. pmid:32738287
  45. 45. Earnshaw VA, Chaudoir SR. From conceptualizing to measuring HIV stigma: a review of HIV stigma mechanism measures. AIDS and Behavior. 2009 Dec 1; 13(6):1160. pmid:19636699
  46. 46. Davtyan M, Brown B, Folayan MO. Addressing Ebola-related stigma: lessons learned from HIV/AIDS. Global health action. 2014 Dec 1; 7(1):26058. pmid:25382685